472 related articles for article (PubMed ID: 27978810)
1. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.
Okura T; Higaki J; Kurata M; Irita J; Miyoshi K; Yamazaki T; Hayashi D; Kohro T; Nagai R;
Circ J; 2009 May; 73(5):885-91. PubMed ID: 19336924
[TBL] [Abstract][Full Text] [Related]
3. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
[TBL] [Abstract][Full Text] [Related]
4. Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.
Perticone M; Tripepi G; Maio R; Cimellaro A; Addesi D; Baggetta R; Sciacqua A; Sesti G; Perticone F
Int J Cardiol; 2017 Sep; 243():473-478. PubMed ID: 28528984
[TBL] [Abstract][Full Text] [Related]
5. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality.
Stack AG; Hanley A; Casserly LF; Cronin CJ; Abdalla AA; Kiernan TJ; Murthy BV; Hegarty A; Hannigan A; Nguyen HT
QJM; 2013 Jul; 106(7):647-58. PubMed ID: 23564632
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis.
Zhao L; Cao L; Zhao TY; Yang X; Zhu XX; Zou HJ; Wan WG; Xue Y
Chin Med J (Engl); 2020 Apr; 133(8):982-993. PubMed ID: 32106120
[TBL] [Abstract][Full Text] [Related]
7. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Tscharre M; Herman R; Rohla M; Hauser C; Farhan S; Freynhofer MK; Huber K; Weiss TW
Atherosclerosis; 2018 Mar; 270():173-179. PubMed ID: 29432935
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid factors do not predict cardiovascular disease and mortality in the general population in the Busselton Health Survey.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Musculoskelet Disord; 2017 May; 18(1):221. PubMed ID: 28549428
[TBL] [Abstract][Full Text] [Related]
9. Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population.
Ahmad MI; Dutta A; Anees MA; Soliman EZ
Am J Cardiol; 2019 Mar; 123(6):882-888. PubMed ID: 30617009
[TBL] [Abstract][Full Text] [Related]
10. Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk.
Li L; Zhao M; Wang C; Zhang S; Yun C; Chen S; Cui L; Wu S; Xue H
Clin Res Cardiol; 2021 Jul; 110(7):1096-1105. PubMed ID: 33846840
[TBL] [Abstract][Full Text] [Related]
11. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
[TBL] [Abstract][Full Text] [Related]
12. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
13. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
14. High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients.
Hsu WL; Li SY; Liu JS; Huang PH; Lin SJ; Hsu CC; Lin YP; Tarng DC
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28067806
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
16. Is increased uric acid a risk factor or a defensive response? The Campania Salute Network.
Mancusi C; Izzo R; Ferrara LA; Rozza F; Losi MA; Canciello G; Pepe M; de Luca N; Trimarco B; de Simone G
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):839-846. PubMed ID: 29898822
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid as a risk predictor for erectile dysfunction.
Salem S; Mehrsai A; Heydari R; Pourmand G
J Sex Med; 2014 May; 11(5):1118-24. PubMed ID: 24621054
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia and Cardiovascular Disease in Patients with Hypertension.
Acevedo A; Benavides J; Chowdhury M; Lopez M; Pena L; Montenegro A; Lievano M; Lombo B
Conn Med; 2016 Feb; 80(2):85-90. PubMed ID: 27024979
[TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia as a prognostic factor after acute coronary syndrome.
Lopez-Pineda A; Cordero A; Carratala-Munuera C; Orozco-Beltran D; Quesada JA; Bertomeu-Gonzalez V; Gil-Guillen VF; Bertomeu-Martinez V
Atherosclerosis; 2018 Feb; 269():229-235. PubMed ID: 29407598
[TBL] [Abstract][Full Text] [Related]
20. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.
Chiou A; England BR; Sayles H; Thiele GM; Duryee MJ; Baker JF; Singh N; Cannon GW; Kerr GS; Reimold A; Gaffo A; Mikuls TR
Arthritis Care Res (Hoboken); 2020 Jul; 72(7):950-958. PubMed ID: 31074584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
